In 2019, he was named editor-in-chief of NEJM. Rubin, who grew up in Brockton, Mass., and earned MD and PhD degrees at Tufts University, was previously chair of the Department of Immunology and Infectious Diseases and the Irene Heinz Given Professor of Immunology and Infectious Diseases.
His career at Harvard Chan School spans more than 20 years, during which he has primarily focused on Mycobacterium tuberculosis, the pathogen that causes human TB and is the leading infectious killer of adults worldwide. He is an esteemed microbiologist and an associate physician specializing in infectious disease at Brigham and Women’s Hospital. Rubin, an adjunct professor of immunology and infectious diseases at Harvard Chan School and editor-in-chief of the New England Journal of Medicine (NEJM), was recognized for pioneering bacterial genetic tools being used to create the next generation of anti- tuberculosis (TB) drugs.
Election to the NAM is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service. Chan School of Public Health, Eric Rubin and Renee Salas, have been elected to the National Academy of Medicine (NAM).
0 kommentar(er)
